ReviewBiomedicines2022

Patient-Derived Organoids: The Beginning of a New Era in Ovarian Cancer Disease Modeling and Drug Sensitivity Testing.

Iason Psilopatis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.